Recifercept (TA-46) is a recombinant human soluble fibroblast growth factor receptor 3, a decoy protein that competes for the ligand of mutant FGFR3.Recifercept is used in the study of chondrodysplasia because it restores normal bone growth by preventing negative inhibitory signaling of mutant FGFR3 in patients with pediatric chondrodysplasia.Recifercept is a recombinant human recombinant fibroblast growth factor receptor 3 that competes for the ligand of mutant FGFR3.
Purity:
98.40%
CAS Number:
[2226238-09-9]
Target:
FGFR
* VAT and and shipping costs not included. Errors and price changes excepted